Evidence map›Paper›PMID 28515121›Full record

ArticleThe EMBO journal2017

AMPKα1-LDH pathway regulates muscle stem cell self-renewal by controlling metabolic homeostasis.

Marine Theret, Linda Gsaier, Bethany Schaffer, Gaëtan Juban, Sabrina Ben Larbi, Michèle Weiss-Gayet, Laurent Bultot, Caterina Collodet, Marc Foretz, Dominique Desplanches and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. A Myocyte-Enriched Long Non-Coding RNA NRMLncR Enhances Myogenesis in Mouse.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. bioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 4 countries.

Marine TheretInstitut Neuromyogène, Université Claude Bernard Lyon 1, Villeurbanne, France.ORCID 0000-0002-8059-8756
Linda GsaierInstitut Neuromyogène, Université Claude Bernard Lyon 1, Villeurbanne, France.
Bethany SchafferDepartment of Genetic and the Cancer Biology Program, University of Stanford, Stanford, CA, USA.
Gaëtan JubanInstitut Neuromyogène, Université Claude Bernard Lyon 1, Villeurbanne, France.ORCID 0000-0002-5845-9223
Sabrina Ben LarbiInstitut Neuromyogène, Université Claude Bernard Lyon 1, Villeurbanne, France.
Michèle Weiss-GayetInstitut Neuromyogène, Université Claude Bernard Lyon 1, Villeurbanne, France.
Laurent BultotNestlé Institute of Health Sciences SA, Lausanne, Switzerland.
Caterina CollodetNestlé Institute of Health Sciences SA, Lausanne, Switzerland.
Marc ForetzUniversité Paris Descartes, Paris, France.
Dominique DesplanchesInstitut Neuromyogène, Université Claude Bernard Lyon 1, Villeurbanne, France.
Pascual SanzInstituto de Biomedecina de Valencia, CSIC, Valencia, Spain.
Zizhao ZangDepartment of Biomedical Engineering, University of Florida, Gainesville, FL, USA.
Lin YangDepartment of Biomedical Engineering, University of Florida, Gainesville, FL, USA.
Guillaume VialINSERM U1042, Université Grenoble Alpes, La Tronche, France.
Benoit ViolletUniversité Paris Descartes, Paris, France.ORCID 0000-0002-0121-0224
Kei SakamotoNestlé Institute of Health Sciences SA, Lausanne, Switzerland.
Anne BrunetDepartment of Genetic and the Cancer Biology Program, University of Stanford, Stanford, CA, USA.
Bénédicte ChazaudInstitut Neuromyogène, Université Claude Bernard Lyon 1, Villeurbanne, France.ORCID 0000-0002-1262-502X
Rémi MounierInstitut Neuromyogène, Université Claude Bernard Lyon 1, Villeurbanne, France remi.mounier@univ-lyon1.fr.ORCID 0000-0003-3464-3322
Université Claude Bernard Lyon 1 · FRNestlé (Switzerland) · CHDélégation Paris 5 · FRStanford University · USUniversity of Florida · USInserm · FRInstituto de Biomedicina de Valencia · ES

Funding

Suppressing glycogen storage with small molecule inhibitors as a therapeutic approach to Lafora DiseaseP01NS097197 · NINDS · UNIVERSITY OF KENTUCKY · PI GAO, TIANYAN · 2016 to 2021
$9.0M
NINDS NIH HHS P01 NS097197
6 · The paper itself

Abstract

Control of stem cell fate to either enter terminal differentiation versus returning to quiescence (self-renewal) is crucial for tissue repair. Here, we showed that AMP-activated protein kinase (AMPK), the master metabolic regulator of the cell, controls muscle stem cell (MuSC) self-renewal. AMPKα1

Indexed as

Cell DifferentiationCell Self RenewalHomeostasisAMP-Activated Protein KinasesAnimalsGlycolysisL-Lactate DehydrogenaseMiceMice, KnockoutMusclesStem CellsAMP-Activated Protein KinasesL-Lactate DehydrogenasePrkaa1 protein, mouseglycolysismetabolic shiftskeletal muscle regenerationstem cell fate

Identifiers

PMID28515121
PMCPMC5494470
OpenAlexW2616847927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.